Immuno-Oncology Drug Development Analytical Tool 2022: 1260 Companies/Partners Who are Developing 3,896 I-O Drugs Where of 2,948 are in Active Development in Cancer Across 629 Different Targets
May 26, 2022 06:28 ET
|
Research and Markets
Dublin, May 26, 2022 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drug Development: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Immuno-Oncology Drug Development:...
Global $140+ Billion Immune Checkpoint Inhibitors Market Opportunity Analysis and Industry Forecasts to 2030
March 29, 2022 05:38 ET
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
Global Immune Checkpoint Inhibitors $30 Billion Market Opportunity
March 15, 2022 05:53 ET
|
Research and Markets
Dublin, March 15, 2022 (GLOBE NEWSWIRE) -- The "Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's...
Global Checkpoint Inhibitors Market (2021 to 2030) - Featuring AstraZeneca, Roche Holding and Pfizer Among Others
December 07, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. This...
Global Head and Neck Squamous Cell Carcinoma Drug Market Report 2021: Limited R&D in HNSCC, Resulting in a Market with Little Competition and a Stagnant Pipeline - Market Will Grow to $5.2B in 2030
November 08, 2021 05:53 ET
|
Research and Markets
Dublin, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The "Head and Neck Squamous Cell Carcinoma - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering....
Global Neuroendocrine Tumors Market & Drug Forecast 2021-2030 | Most Important Unmet Needs and the Projected Impact of 5 Late-Stage Pipeline Agents Entering the Market
October 14, 2021 07:13 ET
|
Research and Markets
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The market of...
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
October 06, 2021 07:13 ET
|
Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...
AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma
September 14, 2021 07:30 ET
|
AzurRx BioPharma, Inc.
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
Global Checkpoint Inhibitor Refractory Cancer Market Report 2021: Marketed Therapies, Emerging Therapies, Checkpoint Inhibitors, Major Markets, Epidemiology - Forecast to 2030
August 17, 2021 03:38 ET
|
Research and Markets
Dublin, Aug. 17, 2021 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitor Refractory Cancer - Market Insights, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's...
Global Peptide Based Cancer Therapeutics Market Share, Size, Trends Analysis Report, Featuring AstraZeneca PLC, Abbott, Allergan plc and Pfizer Inc.
April 27, 2021 04:38 ET
|
Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Cancer Type; By Mode of Mechanism, By...